A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients

Clinical trial NCT05479045 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05479045
Sponsor: Georgetown University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Stage IV Ovarian Cancer Stage III Ovarian Cancer Stage 3

Start date: 2026-09-01
Primary completion: 2027-11-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.